anti-pTag CAR-T cell therapy Adapter CAR (Miltenyi Biotec)

N/A

Report date: 2025/01/26 19:25:32

Base Information

Drug Nameanti-pTag CAR-T cell therapy Adapter CAR (Miltenyi Biotec)

Drug Alias NamepTag AdCAR T cells

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsLymphoma, Non-HodgkinLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMiltenyi Biotec BV & Co KG

China Registration ClassN/A

Develop Information

Active CompaniesMiltenyi Biotec BV & Co KG

Inactive CompaniesN/A

Active IndicationsLymphoma, Non-HodgkinLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A